Anselamimab Biosimilar - Research Grade

Human

SAA1ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P0DJI8

Blue ice

Serum amyloid A1 (SAA1) is an acute-phase protein implicated in inflammation and amyloid deposition, studied across inflammatory and amyloidosis research. This anti-human SAA1 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of anselamimab, provided strictly for research use only. Built to rigorous in vivo standards and low in endotoxin, it is manufactured in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. It serves as a consistent control and active reagent in protein-binding assays, in vitro functional screening, and in vivo models of inflammation and amyloid-related disease.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks